| 摘要 |
The present invention refers to a novel pharmaceutical composition of Losartan and Atorvastatin for treating hypertension associated with dyslipidemia. On the other hand hypertension is defined as the chronic increase in the systolic and diastolic blood pressure, also representing one of the most frequent chronic diseases suffered by humanity. The blood pressure is a value that acquires relevance when the blood pressure values, diastolic (over 80 mmHg) and systolic (increases higher than 120 mmHg, cause a high morbid-mortality in most of the individuals of all studied populations, at any age and both sexes and, according to the World Health Organization and the international society of hypertension, the levels of blood pressure may result optimum when the systolic blood pressure is lower than 120 mmHg and the diastolic pressure 80 mmHg. Said values are based on the determination of the blood pressure in clinics and not in ambulatory conditions. For ambulatory conditions the pressure is controlled for 24 hrs. and has values higher than 125/80 mmHg.
|
